Whittier Trust CO Novo Cure LTD Transaction History

Whittier Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$63.98 - $85.37 $47,345 - $63,173	740 New	740 $0
Q2 2020 Jul 10, 2020	SELL	$57.2 - $74.41 $11,440 - $14,882	-200 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$57.05 - $95.75 $11,410 - $19,150	200 New	200 $13,000
Q2 2019 Jul 23, 2019	SELL	$42.22 - $63.23 $548 - $821	-13 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$31.96 - $56.12 $415 - $729	13 New	13 $1,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.03B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.